These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 37867263)

  • 1. Flavonoid-metal ion Complexes as Potent Anticancer Metallodrugs: A Comprehensive Review.
    Zangade SB; Dhulshette BS; Patil PB
    Mini Rev Med Chem; 2024; 24(10):1046-1060. PubMed ID: 37867263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metal complexes of flavonoids: their synthesis, characterization and enhanced antioxidant and anticancer activities.
    Khater M; Ravishankar D; Greco F; Osborn HM
    Future Med Chem; 2019 Nov; 11(21):2845-2867. PubMed ID: 31722558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transition Metal Coordination Complexes of Flavonoids: A Class of Better Pharmacological Active Molecules to Develop New Drugs.
    Jayaprakash S; Ramesh S; Karthikeyan A; Murugappan S; Sidharthan P; Selvaraj S
    Anticancer Agents Med Chem; 2023; 23(4):417-431. PubMed ID: 35619308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antioxidant properties of flavonoid metal complexes and their potential inclusion in the development of novel strategies for the treatment against neurodegenerative diseases.
    Rodríguez-Arce E; Saldías M
    Biomed Pharmacother; 2021 Nov; 143():112236. PubMed ID: 34649360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Insight into the Effect of Schiff Base and their d and f Block Metal Complexes on Various Cancer Cell Lines as Anticancer Agents: A Review.
    Presenjit ; Chaturvedi S; Singh A; Gautam D; Singh K; Mishra AK
    Anticancer Agents Med Chem; 2024; 24(7):488-503. PubMed ID: 38279753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Organoselenium transition metal complexes as promising candidates in medicine area.
    Kostić M; Marjanović J; Divac V
    J Biol Inorg Chem; 2024 Sep; 29(6):555-571. PubMed ID: 39123093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flavonoid-metal ion complexes: a novel class of therapeutic agents.
    Selvaraj S; Krishnaswamy S; Devashya V; Sethuraman S; Krishnan UM
    Med Res Rev; 2014 Jul; 34(4):677-702. PubMed ID: 24037904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antioxidant vs. Prooxidant Properties of the Flavonoid, Kaempferol, in the Presence of Cu(II) Ions: A ROS-Scavenging Activity, Fenton Reaction and DNA Damage Study.
    Simunkova M; Barbierikova Z; Jomova K; Hudecova L; Lauro P; Alwasel SH; Alhazza I; Rhodes CJ; Valko M
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Schiff Bases and their Metal Complexes as Potential Anticancer Candidates: A Review of Recent Works.
    Tadele KT; Tsega TW
    Anticancer Agents Med Chem; 2019; 19(15):1786-1795. PubMed ID: 30827264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel metals and metal complexes as platforms for cancer therapy.
    Frezza M; Hindo S; Chen D; Davenport A; Schmitt S; Tomco D; Dou QP
    Curr Pharm Des; 2010 Jun; 16(16):1813-25. PubMed ID: 20337575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondria-Targeting Anticancer Metal Complexes.
    Erxleben A
    Curr Med Chem; 2019; 26(4):694-728. PubMed ID: 29521200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and anticancer activity of mixed ligand 3d metal complexes.
    Chu B; Mo X; Chen Z; Zhang M; Liang Y; Hu H; Liu D; Liang F
    Metallomics; 2021 Apr; 13(4):. PubMed ID: 33755727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potent Inhibition of Thioredoxin Reductase by the Rh Derivatives of Anticancer M(arene/Cp*)(NHC)Cl
    Truong D; Sullivan MP; Tong KKH; Steel TR; Prause A; Lovett JH; Andersen JW; Jamieson SMF; Harris HH; Ott I; Weekley CM; Hummitzsch K; Söhnel T; Hanif M; Metzler-Nolte N; Goldstone DC; Hartinger CG
    Inorg Chem; 2020 Mar; 59(5):3281-3289. PubMed ID: 32073260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perspectives of medicinally privileged chalcone based metal coordination compounds for biomedical applications.
    Mahapatra DK; Bharti SK; Asati V; Singh SK
    Eur J Med Chem; 2019 Jul; 174():142-158. PubMed ID: 31035237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on some metal complexes of quinoxaline based unsymmetric ligand: Synthesis, spectral characterization, in vitro biological and molecular modeling studies.
    Dhanaraj CJ; Johnson J
    J Photochem Photobiol B; 2016 Aug; 161():108-21. PubMed ID: 27236046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structurally characterized gallium-chrysin complexes with anticancer potential.
    Halevas E; Mavroidi B; Antonoglou O; Hatzidimitriou A; Sagnou M; Pantazaki AA; Litsardakis G; Pelecanou M
    Dalton Trans; 2020 Feb; 49(8):2734-2746. PubMed ID: 32064490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving Cytotoxicity against Breast Cancer Cells by Using Mixed-Ligand Ruthenium(II) Complexes of 2,2'-Bipyridine, Amino Acid, and Nitric Oxide Derivatives as Potential Anticancer Agents.
    Gaspari APS; da Silva RS; Carneiro ZA; de Carvalho MR; Carvalho I; Pernomian L; Ferreira LP; Ramos LCB; de Souza GA; Formiga ALB
    Anticancer Agents Med Chem; 2021; 21(12):1602-1611. PubMed ID: 33081686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, Characterization, Antimicrobial and Anticancer Studies of Metal Complexes of 2-methoxy-4-((3-methylpyridin-2-ylimino)methyl)phenol.
    Mishra A; Tahlan S; Ramasamy K; Lim SM; Shah SAA; Narasimhan B
    Mini Rev Med Chem; 2020; 20(13):1311-1317. PubMed ID: 32368977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metal N-heterocyclic carbene complexes as potential antitumor metallodrugs.
    Liu W; Gust R
    Chem Soc Rev; 2013 Jan; 42(2):755-73. PubMed ID: 23147001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trizbenzim, Cu-Trizbenzim and Zn-Trizbenzim as G-Quadruplex Inducing and Stabilizing Compounds on Human Telomeric Sequence and their Anticancer Properties.
    Renuga D; Maheswari PU; Begum KMMS; Prabaharan D
    Anticancer Agents Med Chem; 2021; 21(17):2407-2418. PubMed ID: 33463477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.